HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Na Zhang Selected Research

Alkyl and Aryl Transferases

12/2021Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity.
12/2019Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.
1/2019NBGNU: a hypoxia-activated tripartite combi-nitrosourea prodrug overcoming AGT-mediated chemoresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Na Zhang Research Topics

Disease

223Neoplasms (Cancer)
12/2022 - 08/2002
44Infections
05/2022 - 05/2008
35Inflammation (Inflammations)
10/2022 - 11/2004
28Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2008
27Neoplasm Metastasis (Metastasis)
06/2022 - 02/2010
25Breast Neoplasms (Breast Cancer)
04/2022 - 10/2010
21Lung Neoplasms (Lung Cancer)
02/2022 - 08/2002
17Carcinogenesis
06/2022 - 12/2008
16Hypoxia (Hypoxemia)
04/2022 - 12/2008
15Fibrosis (Cirrhosis)
10/2022 - 01/2013
12Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 08/2011
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 07/2006
10Necrosis
08/2022 - 09/2004
9Glioma (Gliomas)
09/2022 - 08/2011
9Alzheimer Disease (Alzheimer's Disease)
06/2022 - 05/2011
9Carcinoma (Carcinomatosis)
01/2021 - 02/2010
9Virus Diseases (Viral Diseases)
01/2019 - 01/2010
8Pain (Aches)
12/2022 - 04/2012
8Type 2 Diabetes Mellitus (MODY)
08/2022 - 01/2016
8Body Weight (Weight, Body)
04/2022 - 03/2009
8Dehydration (Water Stress)
10/2021 - 11/2008
8Lymphatic Metastasis
01/2021 - 05/2011
8Melanoma (Melanoma, Malignant)
01/2020 - 06/2007
8Ischemia
01/2018 - 11/2004
7Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 01/2015
7Hypertension (High Blood Pressure)
09/2022 - 01/2016
7Adenocarcinoma of Lung
03/2022 - 01/2014
7Ischemic Stroke
01/2022 - 02/2010
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 04/2014
7Atherosclerosis
01/2022 - 08/2014
7Parkinson Disease (Parkinson's Disease)
06/2021 - 01/2017
7Obesity
01/2021 - 01/2011
6Stomach Neoplasms (Stomach Cancer)
05/2022 - 01/2015
6Heart Failure
04/2021 - 03/2014
6Cognitive Dysfunction
04/2021 - 05/2017
6Prostatic Neoplasms (Prostate Cancer)
03/2021 - 06/2009
6Acquired Immunodeficiency Syndrome (AIDS)
02/2021 - 05/2011
6Myocardial Infarction
01/2021 - 02/2011
6Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2017
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 12/2011
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2020 - 11/2012

Drug/Important Bio-Agent (IBA)

57Proteins (Proteins, Gene)FDA Link
08/2022 - 07/2009
50Pharmaceutical PreparationsIBA
01/2022 - 12/2003
22Therapeutic UsesIBA
09/2022 - 07/2004
22LipidsIBA
05/2022 - 01/2010
19DNA (Deoxyribonucleic Acid)IBA
12/2021 - 05/2008
18Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2014
16Biological ProductsIBA
10/2022 - 11/2012
16Small Interfering RNA (siRNA)IBA
01/2022 - 02/2010
15Long Noncoding RNAIBA
05/2022 - 12/2017
14Messenger RNA (mRNA)IBA
04/2022 - 08/2011
14CytokinesIBA
10/2021 - 07/2004
14Liposomes (Liposome)IBA
07/2020 - 06/2008
13Glucose (Dextrose)FDA LinkGeneric
09/2022 - 05/2010
13MicroRNAs (MicroRNA)IBA
02/2021 - 01/2014
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2004
11Interleukin-6 (Interleukin 6)IBA
08/2022 - 01/2013
11AntibodiesIBA
01/2022 - 10/2010
11Peptides (Polypeptides)IBA
01/2022 - 06/2007
11EnzymesIBA
01/2022 - 07/2009
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2019 - 12/2008
10Paclitaxel (Taxol)FDA LinkGeneric
04/2022 - 06/2009
10RNA (Ribonucleic Acid)IBA
01/2022 - 09/2012
10ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2006
10LigandsIBA
01/2021 - 12/2012
9AntioxidantsIBA
10/2021 - 07/2013
9AntigensIBA
01/2021 - 10/2008
9MicellesIBA
07/2020 - 01/2011
8Adenosine Triphosphate (ATP)IBA
01/2022 - 05/2010
8AcidsIBA
11/2021 - 01/2009
8Oxygen (Dioxygen)IBA
07/2021 - 10/2010
8CaspasesIBA
01/2021 - 09/2004
8Antiviral Agents (Antivirals)IBA
10/2020 - 01/2013
7CollagenIBA
04/2022 - 01/2016
7CateninsIBA
01/2022 - 09/2015
7Docetaxel (Taxotere)FDA Link
01/2022 - 01/2012
7Sorafenib (BAY 43-9006)FDA Link
01/2022 - 03/2014
7SolutionsIBA
03/2021 - 12/2011
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2012
7salicylhydroxamic acid (SHAM)IBA
01/2021 - 05/2014
6Indicators and Reagents (Reagents)IBA
08/2022 - 02/2005
6Tyrosine Kinase InhibitorsIBA
05/2022 - 12/2011
6Estrogen ReceptorsIBA
04/2022 - 01/2017
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 07/2009
6Hormones (Hormone)IBA
10/2021 - 09/2011
6C-Reactive ProteinIBA
01/2021 - 01/2020
6Casein Kinase II (Casein Kinase 2)IBA
02/2020 - 02/2015
6MethyltransferasesIBA
01/2020 - 06/2016
6Transcription Factors (Transcription Factor)IBA
12/2019 - 08/2002

Therapy/Procedure

112Therapeutics
12/2022 - 07/2006
40Drug Therapy (Chemotherapy)
05/2022 - 01/2010
20Radiotherapy
02/2022 - 09/2009
19Immunotherapy
05/2022 - 08/2012
15Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 01/2009
8Neoadjuvant Therapy
01/2021 - 03/2015
7Precision Medicine
01/2022 - 07/2012
7Acupuncture Therapy
10/2021 - 01/2020
7Aftercare (After-Treatment)
01/2021 - 04/2012
6Fluid Therapy (Oral Rehydration Therapy)
10/2021 - 11/2008
6Transplantation
08/2021 - 02/2011